Discrepancy of interleukin-6 levels between end-stage renal disease patients and patients with acute-phase response with increased lipoprotein(a) concentrations

Author： Yun K. A.   Lee W.   Min W. K.   Chun S.   Lee Y. W.   Kim S. B.   Park J. S.   Yang W. S.   Park H.   Hwang S. H.  

Publisher： Informa Healthcare

ISSN： 0036-5513

Source： Scandinavian Journal of Clinical and Laboratory Investigation, Vol.64, Iss.3, 2004-06, pp. : 223-228

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Antibody Response to Hepatitis B Vaccine in End-Stage Renal Disease Patients

By  

Nephron Clin Pract, Vol. 103, Iss. 3, 2006-03 ,pp. : c89-c93

Karger

Access to resources Recommend Favorite

Deferasirox in thalassemia patients with end‐stage renal disease

By  

AMERICAN JOURNAL OF HEMATOLOGY, Vol. 91, Iss. 10, 2016-10 ,pp. : E456-E457

John Wiley & Sons Inc

Access to resources Recommend Favorite

High‐density lipoprotein from end‐stage renal disease patients exhibits superior cardioprotection and increase in sphingosine‐1‐phosphate

By  

EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (ELECTRONIC), Vol. 48, Iss. 2, 2018-02 ,pp. : n/a-n/a

John Wiley & Sons Inc

Access to resources Recommend Favorite

The clinical response and systemic effects of non‐surgical periodontal therapy in end‐stage renal disease patients: a 6‐month randomized controlled clinical trial

By  

JOURNAL OF CLINICAL PERIODONTOLOGY, Vol. 42, Iss. 6, 2015-06 ,pp. : 537-546

John Wiley & Sons Inc

Access to resources Recommend Favorite

AlphaLISA versus ELISA-based detection of interleukin 18 in healthy subjects and patients with end-stage renal disease

By Peters Christian D.   Jespersen Bente   Nørregaard Rikke  

Scandinavian Journal of Clinical and Laboratory Investigation, Vol. 72, Iss. 8, 2012-12 ,pp. : 583-592

Informa Healthcare

Access to resources Recommend Favorite